Description
Feravir 800 mg – Favipiravir High-Strength Antiviral Tablets
Feravir 800 mg is a high-dose formulation of Favipiravir, an antiviral drug used under medical supervision for the treatment of mild to moderate COVID-19 and other RNA virus infections. Favipiravir works by inhibiting viral RNA polymerase, helping reduce viral replication and supporting faster recovery in early-stage infections.
Key Benefits:
- High-strength 800 mg tablet reduces pill burden
- May help lower viral load and speed up recovery
- Commonly used in early COVID-19 treatment (where approved)
- Favipiravir is well-studied for its antiviral action on RNA viruses
How to Use:
Feravir 800 mg should be taken orally as prescribed by your doctor. Usually part of a loading dose followed by a reduced daily dose. Do not exceed the prescribed amount or duration.
Precautions:
- Not safe for use during pregnancy or breastfeeding
- May cause elevated liver enzymes or uric acid levels
- Requires prescription and medical supervision
- Not a substitute for vaccines or standard care
Storage Instructions:
Store at room temperature (below 30°C), away from moisture and heat. Keep away from children and pets.
Frequently Asked Questions (FAQs)
1. What is Feravir 800 mg used for?
Feravir 800 mg contains Favipiravir and is used in the treatment of mild to moderate COVID-19 in certain countries. It may also be used for other RNA virus infections under physician guidance.
2. How is the 800 mg strength different from 200 or 400 mg?
The 800 mg tablet offers a higher dose in one pill, reducing the number of tablets needed per day and improving convenience during treatment.
3. Is this approved for COVID-19 treatment?
Favipiravir is approved for emergency use in countries like India, Russia, and Japan for mild to moderate COVID-19. Regulatory status may vary by country.
4. Are there side effects?
Common side effects include elevated uric acid, mild gastrointestinal upset, or liver enzyme elevations. Always monitor your health and report unusual symptoms to your doctor.
5. Can I take this during pregnancy?
No. Favipiravir is not recommended during pregnancy or breastfeeding due to potential harm to the fetus.
6. How long is the treatment course?
Typically 5 to 14 days, depending on the condition and medical advice. Always complete the full course as prescribed.
